.. AbilTo, Aetna announce new program to help members with diabetes combat depression The combination of depression and diabetes is common and potentially dangerous. People who have depression will get it hard to make the lifestyle changes had a need to manage diabetes. If not really well managed, diabetes often leads to additional health issues, like heart, kidney and circulatory disease. This group twice is as likely as others to suffer from depression, said Michael Golinkoff, Ph.D., senior advisor, Aetna Behavioral Health Procedures. If we can help members successfully manage depression, we can help people control diabetes and have better health. Related StoriesNew Cleveland Clinic study shows bariatric surgery is safe choice for managing type 2 diabetes in overweight or mildly obese patientsHeart attack patients diagnosed and treated for diabetes knowledge improved cardiac outcomesBetalin launches brand-new EMP technology that could transform diabetes treatment Aetna’s Care Management groups identify eligible associates and invite them to become listed on AbilTo’s Diabetes Forum.AACR dramatic and fast responses in TRK fusion individuals Loxo Oncology, Inc., a biopharmaceutical organization innovating the development of selective medications for individuals with genetically defined cancers highly, today announced new outcomes from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase signaling molecules, and the first preclinical data for its RET and FGFR applications. The data are being shown at the 2015 AACR-NCI-EORTC International Meeting on Molecular Targets and Tumor Therapeutics in Boston.